Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Gupta D, Peshavaria M, Monga N, Jetton TL, Leahy JL
Kosher Non GMO Organic Gluten Free Fairtrade Organic Coconut Sugar We find the best coconut sap throughout Indonesia and blend them for a result that celebrates the natural flavor and aroma of the coconut
The fact that it influences actin tells you a lot about why researchers treat it differently from BPC-157
Many of you also want to know, "are GLP-1 patches FDA approved?" This is a critical question